Diabetic Retinopathy — How Diabetes Affects the Eyes

Diabetes affects every blood vessel in the body, including the delicate network of vessels in the retina. Because the retina is one of the most metabolically active tissues in the body, it is particularly vulnerable. Over time, those vessels can begin to leak, drop out, or trigger the growth of abnormal new vessels that cause further damage. This spectrum of damage to the retina is what we call diabetic retinopathy.

The disease process is gradual, and closely linked to how long you have had diabetes and how well it has been controlled over that time. But one of the most important things to understand is that serious damage can develop silently — vision can be completely normal until suddenly it is not. Regular monitoring is the only way to catch this before it threatens sight.

Almost all the severe vision loss I see from diabetes could have been prevented, in patients who skipped regular review and came in when everything had gone wrong.

What Eye Problems Does Diabetes Cause?

Diabetic retinopathy begins with microscopic changes in the small blood vessels of the retina. Over years, these can gradually build toward vision-threatening problems:

Both are treatable, particularly when detected early, and the two can develop in the same eye.

Why Diabetic Retinopathy Often Has No Warning Signs

Proliferative diabetic retinopathy — the more advanced and immediately dangerous form — can develop with no symptoms at all. The abnormal new vessels produce no warning signs until they bleed. When that bleeding happens, the vision loss can be sudden and severe.

Many people who lose vision from diabetic retinopathy felt that their eyesight was perfectly normal beforehand. By the time symptoms appear, the retinal damage may already be advanced. Regular diabetic eye examinations are designed to detect problems before they affect vision, when treatment is often simpler and more successful.

Seek Urgent Assessment

A vitreous haemorrhage normally presents with a sudden shower of inky, dark, stringy floaters. This is the typical first sign of a bleed into the back of the eye, which often blurs into a general haze over the following day or so.

Any dark shadow or veil across part of your vision, flashes of light, or other new visual symptoms also need urgent review, as they could indicate a retinal detachment.

For urgent review, call our rooms on (02) 8544 0719 to arrange an urgent appointment. After hours, Sydney Eye Hospital Emergency can provide assessment.

Vitreous haemorrhage from proliferative diabetic retinopathy
Vitreous haemorrhage — bleeding into the eye from fragile new vessels

Stages of Diabetic Retinopathy

Diabetic retinopathy is graded by severity, which guides treatment and how often your retina needs to be reviewed.

Mild non-proliferative diabetic retinopathy
Mild non-proliferative diabetic retinopathy — early retinal changes
Proliferative diabetic retinopathy with neovascularisation
Proliferative diabetic retinopathy — abnormal new vessels growing on the retinal surface

Factors that increase the risk of progression include longer duration of diabetes, poor glycaemic control, high blood pressure, renal disease, and pregnancy.

When Should You Have a Diabetic Eye Check?

Every person with diabetes should have a diabetic eye check — sometimes called diabetic eye screening or retinopathy screening — ideally at or around the time of diagnosis, to establish the starting point of their retinal health. How often you need follow-up depends on what is found at that initial review.

More urgent review is appropriate if you have proliferative changes, centre-involving macular oedema, pre-existing retinopathy in pregnancy, or any sudden change in vision.

Diabetic retinopathy is also a marker of wider blood vessel disease. If retinopathy is found, it is worth discussing with your GP or endocrinologist whether your blood glucose, blood pressure, lipids, and kidney function are all being monitored closely.

Treatment — Injections for Diabetic Macular Oedema

Intravitreal injections are the primary treatment for diabetic macular oedema affecting central vision. Anti-VEGF medications reduce vascular leakage, decrease retinal swelling, and protect the macula. In selected cases — particularly where the response to anti-VEGF therapy is incomplete — a steroid implant may be used instead or in addition.

Treatment response is monitored with OCT imaging at every visit, and the schedule is adjusted accordingly.

Fundus photograph of diabetic macular oedema with hard exudates ringing the macula
Retinal photograph: hard exudates ring the macula, marking where the damaged vessels have been leaking.
OCT scan showing diabetic macular oedema
OCT: the same disease seen in cross-section, showing the macular swelling that reduces vision.
What to expect from eye injections

Treatment — Laser for Proliferative Diabetic Retinopathy

When areas of the retina are starved of oxygen and driving the growth of abnormal new vessels, retinal laser treatment is used to reduce that stimulus. By treating the oxygen-deprived peripheral retina, laser reduces the signal for new vessel growth and protects the eye from bleeding and further complications.

The laser is applied to the oxygen-starved mid-peripheral retina — the tissue driving the abnormal vessels — in order to protect the central retina you rely on for detailed vision. Because this addresses the underlying cause rather than simply suppressing it, the regression of the new vessels tends to be lasting. Occasionally, even after reasonably heavy laser, the neovascular process recurs and further, heavier laser is needed — that is the exception rather than the rule, and it is why the retina is reviewed carefully after treatment.

In practice, injections and laser are often used together — injections can rapidly suppress new vessel activity while a course of laser treatment is being completed, reducing the risk of a vitreous haemorrhage during that period. The important difference is that the injection effect is temporary, whereas the laser provides the more durable foundation.

Active proliferative diabetic retinopathy with haemorrhage despite prior panretinal laser
Before: active new vessels have recurred despite reasonably heavy panretinal laser, with pre-retinal and vitreous haemorrhage.
Proliferative diabetic retinopathy regressed after additional panretinal laser
After: following additional panretinal laser the neovascular process has regressed — the durable response laser aims for. Same patient.
Learn more about retinal laser treatment Laser or injections for proliferative retinopathy? — A/Prof Hunt

Research in Diabetic Retinopathy

A/Prof Hunt's involvement with the Fight Retinal Blindness! registry includes research on treatment outcomes in diabetic macular oedema — examining how patients respond over years of therapy, when treatment intervals can be safely extended, and what predicts the best long-term vision. This work directly informs the way diabetic retinopathy is managed in the consulting room.

See A/Prof Hunt's publications

Diabetic Retinopathy Assessment and Treatment

Eye Surgeons Miranda offers baseline assessments for newly diagnosed patients, ongoing retinopathy monitoring, intravitreal injections for diabetic macular oedema, and laser treatment for proliferative disease. Referrals are welcome from GPs, endocrinologists, and optometrists, and urgent cases are seen promptly.

Diabetic retinal examination

If you have diabetes and haven't had a recent retinal examination, or you've noticed any change in vision, arrange an assessment. Early review is always better than waiting for symptoms.

(02) 8544 0719 Mon – Fri, 8:00am – 4:30pm
Call the practice (02) 8544 0719